This is an unprecedented time. It is the dedication of healthcare workers that will lead us through this crisis. Thank you for everything you do.

      Calc Function

    • Calcs that help predict probability of a diseaseDiagnosis
    • Subcategory of 'Diagnosis' designed to be very sensitiveRule Out
    • Disease is diagnosed: prognosticate to guide treatmentPrognosis
    • Numerical inputs and outputsFormula
    • Med treatment and moreTreatment
    • Suggested protocolsAlgorithm

    Disease

    Select...

    Specialty

    Select...

    Chief Complaint

    Select...

    Organ System

    Select...

    Patent Pending

    Severe Community-Acquired Pneumonia (SCAP) Score

    Predicts risk of adverse outcomes in CAP patients in the ED.

    IMPORTANT

    Launched during COVID-19 crisis. COVID-19 Resource Center.

    Tips for COVID-19: Use to determine floor vs. ICU. Likely similar performance to SMART-COP.

    When to Use
    Pearls/Pitfalls
    Why Use

    In the ED, after diagnosis of community-acquired pneumonia is made, calculating SCAP may help predict the chance for "severe CAP", defined by adverse outcomes including inpatient mortality, septic shock, and/or need for mechanical ventilation.

    • High risk SCAP showed higher rates of adverse outcomes than high risk PSI and CURB-65, potentially helping choose which patients are at most need for the ICU with higher specificity (Yandiola 2009).
    • All validations were done in the same Spanish hospital network, by researchers from the same hospital, so may not be generalizable and there is still room for robust external validation.

    • If applying to a patient with potential COVID-19, keep in mind that age has a much stronger odds ratio for increasing mortality risk in COVID-19 patients than with other viral PNA patients.

    Assists with disposition decision after diagnosing CAP in the ED.

    No
    0
    Yes
    +13
    No
    0
    Yes
    +11
    No
    0
    Yes
    +9
    No
    0
    Yes
    +5
    No
    0
    Yes
    +5
    No
    0
    Yes
    +6
    No
    0
    Yes
    +5
    No
    0
    Yes
    +5
    Confirmed positive
    Suspected
    Unlikely
    Confirmed negative

    Result:

    Please fill out required fields.

    Next Steps
    Evidence
    Creator Insights
    Dr. Pedro P. España

    About the Creator

    Pedro P. España, MD, PhD, is clinical chief of pneumology at the Galdakao-Usansolo Hospital in Spain. His research has been utilized in many different hospitals to predict the risk of adverse outcomes in ED patients with community-acquired pneumonia. Dr. España’s primary research is focused on diagnosis of severe community-acquired pneumonia and the connection between the disease etiology and patient characteristics.

    To view Dr. Pedro P. España's publications, visit PubMed

    Are you Dr. Pedro P. España? Send us a message to review your photo and bio, and find out how to submit Creator Insights!
    MDCalc loves calculator creators – researchers who, through intelligent and often complex methods, discover tools that describe scientific facts that can then be applied in practice. These are real scientific discoveries about the nature of the human body, which can be invaluable to physicians taking care of patients.
    About the Creator
    Dr. Pedro P. España
    Are you Dr. Pedro P. España?